499 related articles for article (PubMed ID: 29894679)
1. LRRK2 and mitochondria: Recent advances and current views.
Singh A; Zhi L; Zhang H
Brain Res; 2019 Jan; 1702():96-104. PubMed ID: 29894679
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
Ilieva NM; Hoffman EK; Ghalib MA; Greenamyre JT; De Miranda BR
Neurobiol Dis; 2024 Jun; 196():106522. PubMed ID: 38705492
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and mitophagy: an emerging role for LRRK2.
Singh F; Ganley IG
Biochem Soc Trans; 2021 Apr; 49(2):551-562. PubMed ID: 33769432
[TBL] [Abstract][Full Text] [Related]
5. The Cell Biology of LRRK2 in Parkinson's Disease.
Usmani A; Shavarebi F; Hiniker A
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
[TBL] [Abstract][Full Text] [Related]
6. Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models.
Chittoor-Vinod VG; Villalobos-Cantor S; Roshak H; Shea K; Abalde-Atristain L; Martin I
J Neurosci; 2020 Aug; 40(32):6234-6249. PubMed ID: 32605938
[TBL] [Abstract][Full Text] [Related]
7. Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality.
Walter J; Bolognin S; Antony PMA; Nickels SL; Poovathingal SK; Salamanca L; Magni S; Perfeito R; Hoel F; Qing X; Jarazo J; Arias-Fuenzalida J; Ignac T; Monzel AS; Gonzalez-Cano L; Pereira de Almeida L; Skupin A; Tronstad KJ; Schwamborn JC
Stem Cell Reports; 2019 May; 12(5):878-889. PubMed ID: 30982740
[TBL] [Abstract][Full Text] [Related]
8. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2
Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
10. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
[TBL] [Abstract][Full Text] [Related]
11.
Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
Elife; 2020 Feb; 9():. PubMed ID: 32057291
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of LRRK2-mediated neurodegeneration.
Tsika E; Moore DJ
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):251-60. PubMed ID: 22441981
[TBL] [Abstract][Full Text] [Related]
14. The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress.
Yakhine-Diop SMS; Rodríguez-Arribas M; Canales-Cortés S; Martínez-Chacón G; Uribe-Carretero E; Blanco-Benítez M; Duque-González G; Paredes-Barquero M; Alegre-Cortés E; Climent V; Aiastui A; López de Munain A; Bravo-San Pedro JM; Niso-Santano M; Fuentes JM; González-Polo RA
Cell Biol Toxicol; 2022 Oct; 38(5):889-911. PubMed ID: 34060004
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
[TBL] [Abstract][Full Text] [Related]
16. Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
Lee KS; Huh S; Lee S; Wu Z; Kim AK; Kang HY; Lu B
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8844-E8853. PubMed ID: 30185553
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
Tozzi A; Tantucci M; Marchi S; Mazzocchetti P; Morari M; Pinton P; Mancini A; Calabresi P
Cell Death Dis; 2018 Feb; 9(2):204. PubMed ID: 29434188
[TBL] [Abstract][Full Text] [Related]
19. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
20. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]